{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T13:24:17Z","timestamp":1772889857576,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,12,7]],"date-time":"2018-12-07T00:00:00Z","timestamp":1544140800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"SciPharm","award":["FA641A0113"],"award-info":[{"award-number":["FA641A0113"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s00109-018-1726-6","type":"journal-article","created":{"date-parts":[[2018,12,7]],"date-time":"2018-12-07T15:02:28Z","timestamp":1544194948000},"page":"201-213","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Treprostinil reduces endothelial damage in murine sinusoidal obstruction syndrome"],"prefix":"10.1007","volume":"97","author":[{"given":"Madeleine","family":"Themanns","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florian","family":"Koban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Bergmayr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicja","family":"Chrzan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"Strohmaier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes","family":"Haybaeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Freissmuth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Zebedin-Brandl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,12,7]]},"reference":[{"issue":"1 Suppl 1","key":"1726_CR1","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.bbmt.2007.10.008","volume":"14","author":"KR Cooke","year":"2008","unstructured":"Cooke KR, Jannin A, Ho V (2008) The contribution of endothelial activation and injury to end-organ toxicity following allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 14(1 Suppl 1):23\u201332","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"1726_CR2","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.jceh.2014.10.002","volume":"4","author":"CQ Fan","year":"2014","unstructured":"Fan CQ, Crawford JM (2014) Sinusoidal obstruction syndrome (hepatic veno-occlusive disease). J Clin Exp Hepatol 4(4):332\u2013346","journal-title":"J Clin Exp Hepatol"},{"issue":"6","key":"1726_CR3","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/bmt.2015.52","volume":"50","author":"M Mohty","year":"2015","unstructured":"Mohty M, Malard F, Abecassis M, Aerts E, Alaskar AS, Aljurf M, Arat M, Bader P, Baron F, Bazarbachi A, Blaise D, Ciceri F, Corbacioglu S, Dalle JH, Duarte RF, Fukuda T, Huynh A, Masszi T, Michallet M, Nagler A, NiChonghaile M, Pagluica T, Peters C, Petersen FB, Richardson PG, Ruutu T, Savani BN, Wallhult E, Yakoub-Agha I, Carreras E (2015) Sinusoidal obstruction syndrome\/veno-occlusive disease: current situation and perspectives\u2014a position statement from the European Society for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant 50(6):781\u2013789","journal-title":"Bone Marrow Transplant"},{"issue":"7","key":"1726_CR4","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1016\/j.bbmt.2016.04.011","volume":"22","author":"C Strouse","year":"2016","unstructured":"Strouse C, Richardson P, Prentice G, Korman S, Hume R, Nejadnik B, Horowitz MM, Saber W (2016) Defibrotide for treatment of severe veno-occlusive disease in pediatrics and adults: an exploratory analysis using data from the Center for International Blood and Marrow Transplant Research. Biol Blood Marrow Transplant 22(7):1306\u20131312","journal-title":"Biol Blood Marrow Transplant"},{"key":"1726_CR5","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1111\/bjh.15267","volume":"181","author":"NA Kernan","year":"2018","unstructured":"Kernan NA, Grupp S, Smith AR, Arai S, Triplett B, Antin JH, Lehmann L, Shore T, Ho VT, Bunin N, Iacobelli M, Liang W, Hume R, Tappe W, Soiffer R, Richardson P (2018) Final results from a defibrotide treatment-IND study for patients with hepatic veno-occlusive disease\/sinusoidal obstruction syndrome. Br J Haematol 181:816\u2013827","journal-title":"Br J Haematol"},{"issue":"3","key":"1726_CR6","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/0049-3848(81)90013-X","volume":"23","author":"R Niada","year":"1981","unstructured":"Niada R, Mantovani M, Prino G, Pescador R, Berti F, Omini C, Folco GC (1981) Antithrombotic activity of a polydeoxyribonucleotidic substance extracted from mammalian organs: a possible link with prostacyclin. Thromb Res 23(3):233\u2013246","journal-title":"Thromb Res"},{"issue":"2\u20133","key":"1726_CR7","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/BF00634228","volume":"331","author":"P Lobel","year":"1985","unstructured":"Lobel P, Schror K (1985) Selective stimulation of coronary vascular PGI2 but not of platelet thromboxane formation by defibrotide in the platelet perfused heart. Naunyn Schmiedeberg's Arch Pharmacol 331(2\u20133):125\u2013130","journal-title":"Naunyn Schmiedeberg's Arch Pharmacol"},{"issue":"2\u20133","key":"1726_CR8","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/0014-2999(93)90864-E","volume":"238","author":"G Bianchi","year":"1993","unstructured":"Bianchi G, Barone D, Lanzarotti E, Tettamanti R, Porta R, Moltrasio D, Cedro A, Salvetti L, Mantovani M, Prino G (1993) Defibrotide, a single-stranded polydeoxyribonucleotide acting as an adenosine receptor agonist. Eur J Pharmacol 238(2\u20133):327\u2013334","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"1726_CR9","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1161\/ATVBAHA.111.240291","volume":"32","author":"IM Francischetti","year":"2012","unstructured":"Francischetti IM, Oliveira CJ, Ostera GR, Yager SB, Debierre-Grockiego F, Carregaro V, Jaramillo-Gutierrez G, Hume JC, Jiang L, Moretz SE, Lin CK, Ribeiro JM, Long CA, Vickers BK, Schwarz RT, Seydel KB, Iacobelli M, Ackerman HC, Srinivasan P, Gomes RB, Wang X, Monteiro RQ, Kotsyfakis M, Sa-Nunes A, Waisberg M (2012) Defibrotide interferes with several steps of the coagulation-inflammation cycle and exhibits therapeutic potential to treat severe malaria. Arterioscler Thromb Vasc Biol 32(3):786\u2013798","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"8","key":"1726_CR10","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1111\/j.1476-5381.1995.tb14942.x","volume":"114","author":"V Sexl","year":"1995","unstructured":"Sexl V, Mancusi G, Baumgartner-Parzer S, Schutz W, Freissmuth M (1995) Stimulation of human umbilical vein endothelial cell proliferation by A2-adenosine and beta 2-adrenoceptors. Br J Pharmacol 114(8):1577\u20131586","journal-title":"Br J Pharmacol"},{"issue":"9","key":"1726_CR11","doi-asserted-by":"publisher","first-page":"5792","DOI":"10.1074\/jbc.272.9.5792","volume":"272","author":"V Sexl","year":"1997","unstructured":"Sexl V, Mancusi G, Holler C, Gloria-Maercker E, Schutz W, Freissmuth M (1997) Stimulation of the mitogen-activated protein kinase via the A2A-adenosine receptor in primary human endothelial cells. J Biol Chem 272(9):5792\u20135799","journal-title":"J Biol Chem"},{"issue":"1\u20132","key":"1726_CR12","first-page":"1","volume":"83","author":"EM Zardi","year":"2007","unstructured":"Zardi EM, Zardi DM, Dobrina A, Afeltra A (2007) Prostacyclin in sepsis: a systematic review. Prostaglandins & other lipid mediators 83(1\u20132):1\u201324","journal-title":"Prostaglandins & other lipid mediators"},{"issue":"1","key":"1726_CR13","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1165\/rcmb.2007-0438OC","volume":"41","author":"M Failla","year":"2009","unstructured":"Failla M, Genovese T, Mazzon E, Fruciano M, Fagone E, Gili E, Barera A, La Rosa C, Conte E, Crimi N, Cuzzocrea S, Vancheri C (2009) 16,16-Dimethyl prostaglandin E2 efficacy on prevention and protection from bleomycin-induced lung injury and fibrosis. Am J Respir Cell Mol Biol 41(1):50\u201358","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"2","key":"1726_CR14","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s12079-010-0089-8","volume":"4","author":"R Stratton","year":"2010","unstructured":"Stratton R, Shiwen X (2010) Role of prostaglandins in fibroblast activation and fibrosis. Journal of cell communication and signaling 4(2):75\u201377","journal-title":"Journal of cell communication and signaling"},{"issue":"3","key":"1726_CR15","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1111\/j.1365-2141.1990.tb02583.x","volume":"74","author":"E Gluckman","year":"1990","unstructured":"Gluckman E, Jolivet I, Scrobohaci ML, Devergie A, Traineau R, Bourdeau-Esperou H, Lehn P, Faure P, Drouet L (1990) Use of prostaglandin E1 for prevention of liver veno-occlusive disease in leukaemic patients treated by allogeneic bone marrow transplantation. Br J Haematol 74(3):277\u2013281","journal-title":"Br J Haematol"},{"issue":"4","key":"1726_CR16","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1111\/j.1365-2141.1993.tb03152.x","volume":"84","author":"SI Bearman","year":"1993","unstructured":"Bearman SI, Shen DD, Hinds MS, Hill HA, McDonald GB (1993) A phase I\/II study of prostaglandin E1 for the prevention of hepatic venocclusive disease after bone marrow transplantation. Br J Haematol 84(4):724\u2013730","journal-title":"Br J Haematol"},{"issue":"1","key":"1726_CR17","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.bcp.2012.03.012","volume":"84","author":"BJ Whittle","year":"2012","unstructured":"Whittle BJ, Silverstein AM, Mottola DM, Clapp LH (2012) Binding and activity of the prostacyclin receptor (IP) agonists, treprostinil and iloprost, at human prostanoid receptors: treprostinil is a potent DP1 and EP2 agonist. Biochem Pharmacol 84(1):68\u201375","journal-title":"Biochem Pharmacol"},{"issue":"7","key":"1726_CR18","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.healun.2012.02.025","volume":"31","author":"R Sadushi-Kolici","year":"2012","unstructured":"Sadushi-Kolici R, Skoro-Sajer N, Zimmer D, Bonderman D, Schemper M, Klepetko W, Glatz J, Jakowitsch J, Lang IM (2012) Long-term treatment, tolerability, and survival with sub-cutaneous treprostinil for severe pulmonary hypertension. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 31(7):735\u2013743","journal-title":"The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation"},{"issue":"9","key":"1726_CR19","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/j.healun.2013.06.008","volume":"32","author":"RL Benza","year":"2013","unstructured":"Benza RL, Tapson VF, Gomberg-Maitland M, Poms A, Barst RJ, McLaughlin VV (2013) One-year experience with intravenous treprostinil for pulmonary arterial hypertension. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 32(9):889\u2013896","journal-title":"The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation"},{"issue":"5","key":"1726_CR20","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.healun.2013.01.1055","volume":"32","author":"SL Siehr","year":"2013","unstructured":"Siehr SL, Ivy DD, Miller-Reed K, Ogawa M, Rosenthal DN, Feinstein JA (2013) Children with pulmonary arterial hypertension and prostanoid therapy: long-term hemodynamics. J Heart Lung Transplant 32(5):546\u2013552","journal-title":"J Heart Lung Transplant"},{"issue":"2","key":"1726_CR21","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1097\/00005344-200408000-00010","volume":"44","author":"K Laliberte","year":"2004","unstructured":"Laliberte K, Arneson C, Jeffs R, Hunt T, Wade M (2004) Pharmacokinetics and steady-state bioequivalence of treprostinil sodium (Remodulin) administered by the intravenous and subcutaneous route to normal volunteers. J Cardiovasc Pharmacol 44(2):209\u2013214","journal-title":"J Cardiovasc Pharmacol"},{"issue":"11","key":"1726_CR22","doi-asserted-by":"publisher","first-page":"6812","DOI":"10.4049\/jimmunol.166.11.6812","volume":"166","author":"RF Schwabe","year":"2001","unstructured":"Schwabe RF, Schnabl B, Kweon YO, Brenner DA (2001) CD40 activates NF-kappa B and c-Jun N-terminal kinase and enhances chemokine secretion on activated human hepatic stellate cells. J Immunol 166(11):6812\u20136819","journal-title":"J Immunol"},{"issue":"12","key":"1726_CR23","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1038\/labinvest.2010.132","volume":"90","author":"RC Huebert","year":"2010","unstructured":"Huebert RC, Jagavelu K, Liebl AF, Huang BQ, Splinter PL, LaRusso NF, Urrutia RA, Shah VH (2010) Immortalized liver endothelial cells: a cell culture model for studies of motility and angiogenesis. Lab Investig 90(12):1770\u20131781","journal-title":"Lab Investig"},{"issue":"6","key":"1726_CR24","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1124\/mol.116.103267","volume":"89","author":"Z Kazemi","year":"2016","unstructured":"Kazemi Z, Bergmayr C, Prchal-Murphy M, Javaheri T, Themanns M, Pham HT, Strohmaier W, Sexl V, Freissmuth M, Zebedin-Brandl E (2016) Repurposing treprostinil for enhancing hematopoietic progenitor cell transplantation. Mol Pharmacol 89(6):630\u2013644","journal-title":"Mol Pharmacol"},{"issue":"40","key":"1726_CR25","doi-asserted-by":"publisher","first-page":"28831","DOI":"10.1074\/jbc.M113.464776","volume":"288","author":"C Bergmayr","year":"2013","unstructured":"Bergmayr C, Thurner P, Keuerleber S, Kudlacek O, Nanoff C, Freissmuth M, Gruber CW (2013) Recruitment of a cytoplasmic chaperone relay by the A2A adenosine receptor. J Biol Chem 288(40):28831\u201328844","journal-title":"J Biol Chem"},{"key":"1726_CR26","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/0076-6879(94)38005-8","volume":"238","author":"RA Johnson","year":"1994","unstructured":"Johnson RA, Alvarez R, Salomon Y (1994) Determination of adenylyl cyclase catalytic activity using single and double column procedures. Methods Enzymol 238:31\u201356","journal-title":"Methods Enzymol"},{"issue":"3","key":"1726_CR27","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1007\/s12013-013-9587-7","volume":"67","author":"L Zeng","year":"2013","unstructured":"Zeng L, An L, Fang T, Pan B, Sun H, Chen C, Cao J, Li Z, Xu K (2013) A murine model of hepatic veno-occlusive disease induced by allogeneic hematopoietic stem cell transplantation. Cell Biochem Biophys 67(3):939\u2013948","journal-title":"Cell Biochem Biophys"},{"issue":"1","key":"1726_CR28","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.yexmp.2014.12.008","volume":"98","author":"J Qiao","year":"2015","unstructured":"Qiao J, Fu J, Fang T, Huang Y, Mi H, Yang N, Chen C, Xu K, Zeng L (2015) Evaluation of the effects of preconditioning regimens on hepatic veno-occlusive disease in mice after hematopoietic stem cell transplantation. Exp Mol Pathol 98(1):73\u201378","journal-title":"Exp Mol Pathol"},{"issue":"10","key":"1726_CR29","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1038\/sj.bmt.1705835","volume":"40","author":"DK Cheuk","year":"2007","unstructured":"Cheuk DK, Wang P, Lee TL, Chiang AK, Ha SY, Lau YL, Chan GC (2007) Risk factors and mortality predictors of hepatic veno-occlusive disease after pediatric hematopoietic stem cell transplantation. Bone Marrow Transplant 40(10):935\u2013944","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"1726_CR30","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1002\/jcp.1041640304","volume":"164","author":"M Refsnes","year":"1995","unstructured":"Refsnes M, Dajani OF, Sandnes D, Thoresen GH, Rottingen JA, Iversen JG, Christoffersen T (1995) On the mechanisms of the growth-promoting effect of prostaglandins in hepatocytes: the relationship between stimulation of DNA synthesis and signaling mediated by adenylyl cyclase and phosphoinositide-specific phospholipase C. J Cell Physiol 164(3):465\u2013473","journal-title":"J Cell Physiol"},{"issue":"6240","key":"1726_CR31","doi-asserted-by":"publisher","first-page":"aaa2340","DOI":"10.1126\/science.aaa2340","volume":"348","author":"Y Zhang","year":"2015","unstructured":"Zhang Y, Desai A, Yang SY, Bae KB, Antczak MI, Fink SP, Tiwari S, Willis JE, Williams NS, Dawson DM, Wald D, Chen WD, Wang Z, Kasturi L, Larusch GA, He L, Cominelli F, Di Martino L, Djuric Z, Milne GL, Chance M, Sanabria J, Dealwis C, Mikkola D, Naidoo J, Wei S, Tai HH, Gerson SL, Ready JM, Posner B, Willson JK, Markowitz SD (2015) TISSUE REGENERATION. Inhibition of the prostaglandin-degrading enzyme 15-PGDH potentiates tissue regeneration. Science 348(6240):aaa2340","journal-title":"Science"},{"issue":"15","key":"1726_CR32","doi-asserted-by":"publisher","first-page":"8885","DOI":"10.1073\/pnas.151217998","volume":"98","author":"DA Rudnick","year":"2001","unstructured":"Rudnick DA, Perlmutter DH, Muglia LJ (2001) Prostaglandins are required for CREB activation and cellular proliferation during liver regeneration. Proc Natl Acad Sci U S A 98(15):8885\u20138890","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"1726_CR33","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1002\/hep.20827","volume":"42","author":"Y Kuzumoto","year":"2005","unstructured":"Kuzumoto Y, Sho M, Ikeda N, Hamada K, Mizuno T, Akashi S, Tsurui Y, Kashizuka H, Nomi T, Kubo A, Kanehiro H, Nakajima Y (2005) Significance and therapeutic potential of prostaglandin E2 receptor in hepatic ischemia\/reperfusion injury in mice. Hepatology 42(3):608\u2013617","journal-title":"Hepatology"},{"key":"1726_CR34","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.jhep.2018.02.009","volume":"69","author":"N Nishizawa","year":"2018","unstructured":"Nishizawa N, Ito Y, Eshima K, Ohkubo H, Kojo K, Inoue T, Raouf J, Jakobsson PJ, Uematsu S, Akira S, Narumiya S, Watanabe M, Majima M (2018) Inhibition of microsomal prostaglandin E synthase-1 facilitates liver repair after hepatic injury in mice. J Hepatol 69:110\u2013120","journal-title":"J Hepatol"},{"issue":"4","key":"1726_CR35","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1111\/bjh.12558","volume":"163","author":"FL Dignan","year":"2013","unstructured":"Dignan FL, Wynn RF, Hadzic N, Karani J, Quaglia A, Pagliuca A, Veys P, Potter MN (2013) BCSH\/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation. Br J Haematol 163(4):444\u2013457","journal-title":"Br J Haematol"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00109-018-1726-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-018-1726-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-018-1726-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,6]],"date-time":"2019-12-06T19:04:51Z","timestamp":1575659091000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00109-018-1726-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,7]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["1726"],"URL":"https:\/\/doi.org\/10.1007\/s00109-018-1726-6","relation":{},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,7]]},"assertion":[{"value":"25 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The experimental protocol was reviewed by the animal ethics committee of the Veterinary University of Vienna, approved by the Austrian Ministry of Science and Research under licenses BMWFW-68.205\/0103-WF\/V\/3b\/2015 and BMWFW-68.205\/0047-V\/3b\/2018 and conducted according to the guidelines of FELASA and ARRIVE.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}